Cancer Research Cancer Epigenetics  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bartolomé, R. A.
Right arrow Articles by Teixidó, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bartolomé, R. A.
Right arrow Articles by Teixidó, J.
[Cancer Research 66, 248-258, January 1, 2006]
© 2006 American Association for Cancer Research


Cell, Tumor and Stem Cell Biology

Activation of Vav/Rho GTPase Signaling by CXCL12 Controls Membrane-Type Matrix Metalloproteinase–Dependent Melanoma Cell Invasion

Rubén A. Bartolomé1, Isabel Molina-Ortiz1, Rafael Samaniego2, Paloma Sánchez-Mateos2, Xosé R. Bustelo3 and Joaquin Teixidó1

1 Department of Immunology, Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas; 2 Servicio de Inmuno-Oncología, Hospital Universitario Gregorio Marañón, Madrid, Spain and 3 Centro de Investigación del Cáncer, Consejo Superior de Investigaciones Científicas, Salamanca, Spain

Requests for reprints: Joaquin Teixidó, Department of Immunology, Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas, Ramiro de Maeztu 9, 28040 Madrid, Spain. Phone: 34-91-8373112; Fax: 34-91-5360432; E-mail: joaquint{at}cib.csic.es.

Melanoma cells express the chemokine receptor CXCR4, which confers invasive signals on binding to its ligand CXCL12. We show here that knocking down membrane-type matrix metalloproteinase (MT1-MMP) expression translates into a blockade of invasion across reconstituted basement membranes and type I collagen gels in response to CXCL12, which is the result of lack of MMP-2 activation. Interference with MMP-2 expression further confirms its important role during this invasion. Vav proteins are guanine-nucleotide exchange factors for Rho GTPases that regulate actin dynamics and gene expression. We show that melanoma cells express Vav1 and Vav2, which are activated by CXCL12 involving Jak activity. Blocking Vav expression by RNA interference results in impaired activation of Rac and Rho by CXCL12 and in a remarkable inhibition of CXCL12-promoted invasion. Importantly, up-regulation of MT1-MMP expression by CXCL12, a mechanism contributing to melanoma cell invasion, is blocked by knocking down Vav expression or by inhibiting Jak. Together, these data indicate that activation of Jak/Vav/Rho GTPase pathway by CXCL12 is a key signaling event for MT1-MMP/MMP-2–dependent melanoma cell invasion. (Cancer Res 2006; 66(1): 248-58)




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
I. Molina-Ortiz, R. A. Bartolome, P. Hernandez-Varas, G. P. Colo, and J. Teixido
Overexpression of E-cadherin on Melanoma Cells Inhibits Chemokine-promoted Invasion Involving p190RhoGAP/p120ctn-dependent Inactivation of RhoA
J. Biol. Chem., May 29, 2009; 284(22): 15147 - 15157.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
R. A. Bartolome, S. Ferreiro, M. E. Miquilena-Colina, L. Martinez-Prats, M. L. Soto-Montenegro, D. Garcia-Bernal, J. J. Vaquero, R. Agami, R. Delgado, M. Desco, et al.
The Chemokine Receptor CXCR4 and the Metalloproteinase MT1-MMP Are Mutually Required during Melanoma Metastasis to Lungs
Am. J. Pathol., February 1, 2009; 174(2): 602 - 612.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. A. Bartolome, N. Wright, I. Molina-Ortiz, F. J. Sanchez-Luque, and J. Teixido
Activated G{alpha}13 Impairs Cell Invasiveness through p190RhoGAP-Mediated Inhibition of RhoA Activity
Cancer Res., October 15, 2008; 68(20): 8221 - 8230.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
B. Annabi, S. Rojas-Sutterlin, C. Laflamme, M.-P. Lachambre, Y. Rolland, H. Sartelet, and R. Beliveau
Tumor Environment Dictates Medulloblastoma Cancer Stem Cell Expression and Invasive Phenotype
Mol. Cancer Res., June 1, 2008; 6(6): 907 - 916.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
C.-H. Tang, T.-W. Tan, W.-M. Fu, and R.-S. Yang
Involvement of matrix metalloproteinase-9 in stromal cell-derived factor-1/CXCR4 pathway of lung cancer metastasis
Carcinogenesis, January 1, 2008; 29(1): 35 - 43.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Y.-C. Chiu, R.-S. Yang, K.-H. Hsieh, Y.-C. Fong, T.-D. Way, T.-S. Lee, H.-C. Wu, W.-M. Fu, and C.-H. Tang
Stromal Cell-Derived Factor-1 Induces Matrix Metalloprotease-13 Expression in Human Chondrocytes
Mol. Pharmacol., September 1, 2007; 72(3): 695 - 703.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. K. Dissanayake, M. Wade, C. E. Johnson, M. P. O'Connell, P. D. Leotlela, A. D. French, K. V. Shah, K. J. Hewitt, D. T. Rosenthal, F. E. Indig, et al.
The Wnt5A/Protein Kinase C Pathway Mediates Motility in Melanoma Cells via the Inhibition of Metastasis Suppressors and Initiation of an Epithelial to Mesenchymal Transition
J. Biol. Chem., June 8, 2007; 282(23): 17259 - 17271.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T.-N. Zhu, H.-J. He, S. Kole, T. D'Souza, R. Agarwal, P. J. Morin, and M. Bernier
Filamin A-mediated Down-regulation of the Exchange Factor Ras-GRF1 Correlates with Decreased Matrix Metalloproteinase-9 Expression in Human Melanoma Cells
J. Biol. Chem., May 18, 2007; 282(20): 14816 - 14826.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
O. Bock, J. Neuse, K. Hussein, K. Brakensiek, G. Buesche, T. Buhr, B. Wiese, and H. Kreipe
Aberrant Collagenase Expression in Chronic Idiopathic Myelofibrosis Is Related to the Stage of Disease but Not to the JAK2 Mutation Status
Am. J. Pathol., August 1, 2006; 169(2): 471 - 481.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.